Jianfen Zhou

819 total citations
19 papers, 667 citations indexed

About

Jianfen Zhou is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Jianfen Zhou has authored 19 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomaterials, 12 papers in Molecular Biology and 8 papers in Biomedical Engineering. Recurrent topics in Jianfen Zhou's work include Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (11 papers) and Nanoplatforms for cancer theranostics (8 papers). Jianfen Zhou is often cited by papers focused on Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (11 papers) and Nanoplatforms for cancer theranostics (8 papers). Jianfen Zhou collaborates with scholars based in China, South Korea and United States. Jianfen Zhou's co-authors include Weiyue Lu, Cao Xie, Linwei Lu, Danni Ran, Zhilan Chai, Changyou Zhan, Jinyang Li, Huitong Ruan, Yanyu Zhang and Kuan Jiang and has published in prestigious journals such as ACS Nano, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

Jianfen Zhou

19 papers receiving 664 citations

Peers

Jianfen Zhou

BIOMA

IMMUN

Mingqing Yuan China

Hannah J. Vaughan United States

B. P. Nikolaev Russia

Xianping Liu China

Zhilan Chai China

Haijing Qu China

Rami W. Chakroun United States

Shruti Shah United States

Di Jiang China

Tatiana O. Abakumova Russia

Mingqing Yuan China

Jianfen Zhou

328 ×0.9

554 ×1.6

BIOMA

502 ×1.5

46 ×0.6

IMMUN

65 ×1.0

Citations per year, relative to Jianfen Zhou Jianfen Zhou (= 1×) peers Mingqing Yuan

Countries citing papers authored by Jianfen Zhou

Since Specialization

Citations

This map shows the geographic impact of Jianfen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfen Zhou more than expected).

Fields of papers citing papers by Jianfen Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfen Zhou. The network helps show where Jianfen Zhou may publish in the future.

Co-authorship network of co-authors of Jianfen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfen Zhou. A scholar is included among the top collaborators of Jianfen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfen Zhou. Jianfen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Meng, Nana, Jiasheng Lu, Jianfen Zhou, et al.. (2025). Improved immunocompatibility of active targeting liposomes by attenuating nucleophilic attack of cyclic RGD peptides on complement 3. Biomaterials. 321. 123350–123350. 5 indexed citations

Li, Jinyang, Jiasheng Lu, Xin Huang, et al.. (2025). Anti-CD33 antibody enhances liposomal co-delivery of cytarabine and daunorubicin for targeted combination chemotherapy. Journal of Controlled Release. 384. 113899–113899. 1 indexed citations

Zhou, Jianfen, Nana Meng, Linwei Lu, et al.. (2024). A novel peptide-drug conjugate for glioma-targeted drug delivery. Journal of Controlled Release. 369. 722–733. 12 indexed citations

Ding, Yuan, Zhilan Chai, Jun Wang, et al.. (2024). All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment. Journal of Controlled Release. 369. 325–334. 19 indexed citations

Ding, Yuan, Jianfen Zhou, Nana Meng, et al.. (2024). All-stage targeted nanodiscs for glioma treatment by inducing cuproptosis and apoptosis of cancer cells and cancer stem cells. Asian Journal of Pharmaceutical Sciences. 20(2). 101010–101010. 2 indexed citations

Lu, Linwei, Jianfen Zhou, Nana Meng, et al.. (2023). Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs. Journal of Controlled Release. 354. 538–553. 16 indexed citations

Luo, Zimiao, Jianfen Zhou, Linwei Lu, et al.. (2022). All-stage targeted therapy for the brain metastasis from triple-negative breast cancer. Acta Pharmaceutica Sinica B. 13(1). 359–371. 16 indexed citations

Luo, Zimiao, Linwei Lu, Nana Meng, et al.. (2022). In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy. Journal of Controlled Release. 346. 32–42. 24 indexed citations

Wang, Songli, Ruifeng Wang, Nana Meng, et al.. (2022). Engineered platelets-based drug delivery platform for targeted thrombolysis. Acta Pharmaceutica Sinica B. 12(4). 2000–2013. 21 indexed citations

10.

Lu, Linwei, Jianfen Zhou, Danni Ran, et al.. (2022). All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals. Journal of Controlled Release. 345. 685–695. 33 indexed citations

11.

Hu, Yang, Kuan Jiang, Dongli Wang, et al.. (2021). Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma. Acta Biomaterialia. 138. 478–490. 45 indexed citations

12.

Hu, Yang, Kuan Jiang, Dongli Wang, et al.. (2021). Core-Shell Lipoplexes Inducing Active Macropinocytosis Promote Intranasal Delivery of c-Myc siRNA for Treatment of Glioblastoma. SSRN Electronic Journal. 1 indexed citations

13.

Song, Jie, Han Zhang, Dongli Wang, et al.. (2021). Hydrogel loading functionalized PAMAM/shRNA complex for postsurgical glioblastoma treatment. Journal of Controlled Release. 338. 583–592. 30 indexed citations

14.

Li, Jinyang, Jiasheng Lu, Jianfen Zhou, et al.. (2020). A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated. Acta Pharmaceutica Sinica B. 11(1). 283–299. 10 indexed citations

15.

Ran, Danni, Jianfen Zhou, Zhilan Chai, et al.. (2020). All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide. Theranostics. 10(9). 4073–4087. 32 indexed citations

16.

Li, Jinyang, Zhilan Chai, Jiasheng Lu, et al.. (2020). ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy. Journal of Controlled Release. 322. 542–554. 16 indexed citations

17.

Guo, Haiyan, Ruifeng Wang, Dongli Wang, et al.. (2020). Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma. Journal of Controlled Release. 320. 63–72. 42 indexed citations

18.

Chai, Zhilan, Danni Ran, Linwei Lu, et al.. (2019). Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano. 13(5). 5591–5601. 303 indexed citations

19.

Ran, Danni, Changyou Zhan, Cao Xie, et al.. (2017). d-Retroenantiomer of Quorum-Sensing Peptide-Modified Polymeric Micelles for Brain Tumor-Targeted Drug Delivery. ACS Applied Materials & Interfaces. 9(31). 25672–25682. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact